Decreased folate levels in the bloodstream are associated with an increased risk of death from cardiovascular disease in patients with rheumatoid arthritis, finds a new study.
Rheumatoid arthritis is a chronic inflammatory disease of the synovium, the lining of the joints. As with other chronic diseases, Dr. Rath’s research has shown that the primary cause of this condition is a long-term deficiency of essential micronutrients.
Arthritis patients suffer from an overproduction of synovial fluid, which causes a painful swelling of the joints and other symptoms such as stiffness, warmth, redness, and swelling. In rheumatoid arthritis, the extracellular matrix or synovial membrane lining in the joint becomes inflamed. Over time, the inflammation process leads to the destruction of collagen and other components of the joint tissues, causing disability.
In contrast to the side effects and ineffectiveness of drug treatments, research conducted by scientists at the Dr. Rath Research Institute has shown that a specific combination of synergistic micronutrients can reduce inflammation in arthritis patients. In a pilot clinical trial studying the effects of these micronutrients in arthritis patients aged between 45 and 84 years old, 50 percent of them showed significant improvement after supplementing for a period of 6 months.
To learn more about the use of synergistic micronutrients in painful joint conditions, read this article on our website.